CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-03 | Mehra Anand Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Humphries William D. Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | Humphries William D. Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +12,250 | 12,250 | ||
| 2021-06-03 | GOWEN MAXINE Director | Grant or award · Restricted Stock Units | +3,356 | 3,356 | ||
| 2021-06-03 | Ali-Jackson Kamil Chief Legal Officer | Sale | −9,492 | $21.96 | $208K | 122,196 |
| 2021-06-02 | Gordon David N. Chief Medical Officer | Sale | −31,114 | $21.50 | $669K | 150,878 |
| 2021-06-02 | Gordon David N. Chief Medical Officer | Sale | −6,800 | $22.26 | $151K | 144,078 |
| 2021-06-02 | Ali-Jackson Kamil Chief Legal Officer | Sale | −12,483 | $21.50 | $268K | 149,324 |
| 2021-06-02 | Ali-Jackson Kamil Chief Legal Officer | Sale | −2,517 | $22.32 | $56K | 146,807 |
| 2021-06-02 | Ali-Jackson Kamil Chief Legal Officer | Sale | −12,732 | $21.51 | $274K | 134,075 |
| 2021-06-02 | Ali-Jackson Kamil Chief Legal Officer | Sale | −2,387 | $22.31 | $53K | 131,688 |
| 2021-06-02 | Monahan Joseph Chief Scientific Officer | Sale | −18,240 | $21.50 | $392K | 88,892 |
| 2021-06-02 | Monahan Joseph Chief Scientific Officer | Sale | −3,550 | $22.31 | $79K | 85,342 |
| 2021-06-02 | Ruffo Frank Chief Financial Officer | Sale | −12,587 | $21.51 | $271K | 172,322 |
| 2021-06-02 | Ruffo Frank Chief Financial Officer | Sale | −2,450 | $22.30 | $55K | 169,872 |
| 2021-06-02 | Walker Neal President and CEO | Sale | −27,743 | $21.51 | $597K | 1,237,699 |
| 2021-06-02 | Walker Neal President and CEO | Sale | −5,517 | $22.30 | $123K | 1,232,182 |
| 2021-06-01 | Gordon David N. Chief Medical Officer | Option exercise | +87,500 | 195,992 | ||
| 2021-06-01 | Gordon David N. Chief Medical Officer | Sale | −9,115 | $22.71 | $207K | 186,877 |
Page 29 of 34 · 680 trades